Immune thrombocytopenia (ITP) trials in United Kingdom

In United Kingdom 8 Also abroad 118

8 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Where
Bristol, Leeds, Leicester, London
Age
18 years to 64 years
People
68 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06721013 · EU 2024-518502-40-00
Phase 3Taking people
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Where
Glasgow, Leeds, Leicester, Liverpool, London, Southampton, Southwark, Stoke-on-Trent
Age
18 years and over
People
171 worldwide
Run by
Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00
Phase 3Taking people
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Where
Glasgow, Leeds, Leicester, Liverpool, London, Southampton, Southwark, Stoke-on-Trent
Age
18 years and over
People
150 worldwide
Run by
Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00
Phase 2Taking people
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Where
Cottingham, London, Plymouth
Age
18 years and over
People
56 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07104565 · EU 2025-521286-27-00
Phase 2/3Taking people
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Where
Cardiff, Glasgow, Manchester
Age
12 years to 17 years
People
24 worldwide
Run by
argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00
Phase 2Not yet taking people in United Kingdom
Study of Zola-cel (BMS-986353), in Participants With Autoimmune Cytopenia (Breakfree-AiCE)
Where
London, Sheffield
Age
18 years and over
People
52 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07603557
Phase 1Taking people
Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia
Where
Leeds
Age
18 years to 80 years
People
42
Run by
Gliknik Inc.
See details and how to joinNCT07605845
Phase 3Taking people
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Where
Birmingham, Bradford, Coventry, Glasgow, Leicester, London, Truro
Age
18 years and over
People
69 worldwide
Run by
argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00